© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 21.3% of MNOV shares are held by financial institutions. CUTLER GROUP LLC / CA is the top corporate investor, holding 0 shares valued at -. A 0% stake in MediciNova, Inc. is owned by the company. BANK OF AMERICA CORP /DE/ owns 148.46K shares valued at $215.27K, which translates its holding of 0.3% of the stake in the company.
Among the MNOV insiders holding of 2.98% of the stake in company, IWAKI YUICHI, President and CEO, holds the largest shares of 780.68K. IZUMI TATSUO, director, is the second largest MNOV insider with ownership of 600K shares. MATSUDA KAZUKO, Chief Medical Officer, stands third with possession of 111.48K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MNOV shares is 37, representing 21.3% of the company's common stock.
CUTLER GROUP LLC / CA, in the last quarter, reduced its stake in MNOV by -100% restricting it's holding to 0 shares of worth nearly -. BANK OF AMERICA CORP /DE/ also lessened -11.61% of the MNOV shares from its portfolio, reducing its holding to 148.46 thousand shares of worth $215.27K. BLACKROCK INC. also shunned MNOV shares holding by -0.6% last quarter which brought its holding to 695.42 thousand shares worth $1.01M.
As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in MNOV by 0.49% in the last quarter. The institutional holder raised its holding to 437.86 thousand shares having worth more than $635.08K. RENAISSANCE TECHNOLOGIES LLC also added 32.34% more shares of MNOV to its portfolio, raising its holding to 230.4 thousand shares of worth $334.00K. XTX TOPCO LTD also increased its MNOV shares holding by 100% which brought its holding to 13.13 thousand shares worth $19.03K.
The insider with the most stakes in MNOV is IWAKI YUICHI , President and CEO at the company. Additionally, MNOV stock is highly held by director Izumi Tatsuo and Chief Medical Officer Matsuda Kazuko among others.
Company executives, directors, and other insiders own 2.98% percent of MediciNova, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which MNOV insiders have sold stock, totaling 0 shares. Insiders that have sold shares include NAGAO HIDEKI, OBRIEN GEOFFREY, and MATSUDA KAZUKO.
There have been 0 transaction(s) during the past 6-months in which MediciNova, Inc. insiders have bought stock, totalling 0 shares
Around 0 MediciNova, Inc. shares are held by insiders, which represents about 2.98% of MNOV stock.
MNOV President and CEO, IWAKI YUICHI holds the largest portfolio of the company's shares. MNOV shares owned by IWAKI total nearly 780.68 thousand.
CUTLER GROUP LLC / CA is the largest institutional owner in MNOV which holds 0 shares worth - or 0% of the total MNOV shares outstanding followed by BANK OF AMERICA CORP /DE/ with ownership of 148.46 thousand shares representing 0.3% of the MNOV ownership. BRIDGEWAY CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 145.15 thousand shares or 0.3% of the ownership worth more than $210.46K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MNOV is concerned, it is a stock which is optionable.
Number of MNOV shares short is 182.20K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 49.05M shares of MNOV are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MNOV has 42.08M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MNOV is 11.2.